PURPOSE: The aim of this study was to evaluate inflammation and tumour imaging with a vascular adhesion protein 1 (VAP-1) targeting peptide (68)Ga-DOTAVAP-P1 in comparison with (18)F-FDG. METHODS: Rats with both subcutaneous human pancreatic adenocarcinoma xenografts and turpentine oil-induced acute sterile inflammation were evaluated by dynamic positron emission tomography (PET) and by digital autoradiography of tissue cryosections. Subsequently, the autoradiographs were combined with histological and immunohistological analysis of the sections. RESULTS: (68)Ga-DOTAVAP-P1 delineated acute, sterile inflammation comparable with (18)F-FDG. However, the tumour uptake of (68)Ga-DOTAVAP-P1 was low in contrast to prominent (18)F-FDG uptake. The standardised uptake values of inflammation and tumours by PET were 1.1 +/- 0.4 (mean +/- SEM) and 0.4 +/- 0.1 for (68)Ga-DOTAVAP-P1 and 2.0 +/- 0.5 and 1.6 +/- 0.8 for (18)F-FDG, respectively. In addition, PET studies showed inflammation to muscle and tumour to muscle ratios of 5.1 +/- 3.1 and 1.7 +/- 0.3 for (68)Ga-DOTAVAP-P1 and 6.2 +/- 0.7 and 4.6 +/- 2.2 for (18)F-FDG, respectively. Immunohistochemistry revealed increased expression of luminal VAP-1 on the endothelium at the site of inflammation and low expression in the tumour CONCLUSION: The (68)Ga-DOTAVAP-P1 PET was able to visualise inflammation better than tumour, which was in accordance with the luminal expression of VAP-1 on vasculature in these experimental models.
PURPOSE: The aim of this study was to evaluate inflammation and tumour imaging with a vascular adhesion protein 1 (VAP-1) targeting peptide (68)Ga-DOTAVAP-P1 in comparison with (18)F-FDG. METHODS:Rats with both subcutaneous humanpancreatic adenocarcinoma xenografts and turpentine oil-induced acute sterile inflammation were evaluated by dynamic positron emission tomography (PET) and by digital autoradiography of tissue cryosections. Subsequently, the autoradiographs were combined with histological and immunohistological analysis of the sections. RESULTS: (68)Ga-DOTAVAP-P1 delineated acute, sterile inflammation comparable with (18)F-FDG. However, the tumour uptake of (68)Ga-DOTAVAP-P1 was low in contrast to prominent (18)F-FDG uptake. The standardised uptake values of inflammation and tumours by PET were 1.1 +/- 0.4 (mean +/- SEM) and 0.4 +/- 0.1 for (68)Ga-DOTAVAP-P1 and 2.0 +/- 0.5 and 1.6 +/- 0.8 for (18)F-FDG, respectively. In addition, PET studies showed inflammation to muscle and tumour to muscle ratios of 5.1 +/- 3.1 and 1.7 +/- 0.3 for (68)Ga-DOTAVAP-P1 and 6.2 +/- 0.7 and 4.6 +/- 2.2 for (18)F-FDG, respectively. Immunohistochemistry revealed increased expression of luminal VAP-1 on the endothelium at the site of inflammation and low expression in the tumour CONCLUSION: The (68)Ga-DOTAVAP-P1 PET was able to visualise inflammation better than tumour, which was in accordance with the luminal expression of VAP-1 on vasculature in these experimental models.
Authors: Tatu J Mäkinen; Petteri Lankinen; Tiina Pöyhönen; Jari Jalava; Hannu T Aro; Anne Roivainen Journal: Eur J Nucl Med Mol Imaging Date: 2005-07-09 Impact factor: 9.236
Authors: Tiina Ujula; Satu Salomäki; Anu Autio; Pauliina Luoto; Tuula Tolvanen; Pertti Lehikoinen; Tapio Viljanen; Hannu Sipilä; Pirkko Härkönen; Anne Roivainen Journal: Mol Imaging Biol Date: 2009-10-02 Impact factor: 3.488
Authors: Mariëtte C A van Kouwen; Jan B M J Jansen; Harry van Goor; Steve de Castro; Wim J G Oyen; Joost P H Drenth Journal: Eur J Nucl Med Mol Imaging Date: 2004-11-12 Impact factor: 9.236
Authors: Anu Autio; Antti Saraste; Nobuyuki Kudomi; Tiina Saanijoki; Jarkko Johansson; Heidi Liljenbäck; Miikka Tarkia; Vesa Oikonen; Hannu T Sipilä; Anne Roivainen Journal: Am J Nucl Med Mol Imaging Date: 2014-09-06
Authors: Jaime Retamal; Jens Sörensen; Mark Lubberink; Fernando Suarez-Sipmann; João Batista Borges; Ricardo Feinstein; Sirpa Jalkanen; Gunnar Antoni; Göran Hedenstierna; Anne Roivainen; Anders Larsson; Irina Velikyan Journal: Am J Nucl Med Mol Imaging Date: 2016-01-28
Authors: Helena Ahtinen; Julia Kulkova; Laura Lindholm; Erkki Eerola; Antti J Hakanen; Niko Moritz; Mirva Söderström; Tiina Saanijoki; Sirpa Jalkanen; Anne Roivainen; Hannu T Aro Journal: EJNMMI Res Date: 2014-08-08 Impact factor: 3.138
Authors: Helena Virtanen; Anu Autio; Riikka Siitonen; Heidi Liljenbäck; Tiina Saanijoki; Petteri Lankinen; Jussi Mäkilä; Meeri Käkelä; Jarmo Teuho; Nina Savisto; Kimmo Jaakkola; Sirpa Jalkanen; Anne Roivainen Journal: Arthritis Res Ther Date: 2015-11-03 Impact factor: 5.156